pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-539 |
Genomic Coordinates | chr14: 101047321 - 101047398 |
Synonyms | MIRN539, hsa-mir-539, MIR539 |
Description | Homo sapiens miR-539 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-539-3p | ||||||||||||||||||||||||||||
Sequence | 49| AUCAUACAAGGACAAUUUCUUU |70 | ||||||||||||||||||||||||||||
Evidence | Not_experimental | ||||||||||||||||||||||||||||
Experiments | |||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TMED10 | ||||||||||||||||||||
Synonyms | P24(DELTA), S31I125, S31III125, TMP21, Tmp-21-I, p23, p24d1 | ||||||||||||||||||||
Description | transmembrane p24 trafficking protein 10 | ||||||||||||||||||||
Transcript | NM_006827 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TMED10 | |||||||||||||||||||||
3'UTR of TMED10 (miRNA target sites are highlighted) |
>TMED10|NM_006827|3'UTR 1 TGAATGAGGCATATTCTCCTCCCACCTTGTACCTCAGCCAGCAGAACATCGCTGGGACGTGCCTGGCCTAAGGCATCCTA 81 CCAACAGCACCATCAAGGCACGTTGGAGCTTTCTTGCCAGAACTGATCTCTTTTGGTGTGGGAGGACATGGGGTACCACC 161 TACACCCAACAAGTCAATGAGGGACTTCTTTTTAATTTGGTAGGATTTTGACTGGTTTTGCAACAATAGGTCTATTATTA 241 GAGTCACCTATGACAAAAAATAGGGGTTACCTAGATAATGCCAAAGTCAGCATTTGTCCTGGGTTCCCTTGTGTGATCTG 321 TTTGGACTATGTTTTCTTTTCTTCTCCCACTTGCTCAGCAGCTTGGGCTTCCATTCTAGTTCTTTTACCAAGATTTTTGT 401 GTGACCATGTTGACTTCATTTGGATTGCCCTCTTTCAATTTCCTTGTGAAAACACCCTTAACTTTCTCTTTACCCTTAGC 481 TGAAATGTTTACATAGCTTCTGGTGATATCTTTTCATGATTTTATATCTCTTAAAATGGTGATGGATGTGACACCTCATA 561 AAAGTGAGCTTTGAACTGTAGATAACTCTTAAAGAAAATGTCATTTTAGACAATTAAAATATTTGTGCTCAACTGCTTGA 641 ACTTTTTTCGTGTATGTGTATTTAATTCTATGCAATATTATCACATGTGTAGATTCATGTGACCACCATCACAAGAGACA 721 GAACAGTTCTGTCACATGGATCCCTTGCACTGCCCTTTTACAGCCGCAGCCACATCCCTTTCTTATACCCTCACCCCAAC 801 CTGTGGCTACCACTGTTCTGTCCTCCATCTCTGTAATTTTGTCATTTCAAGAATGTTGTATGAATGGAATCATACAGAAT 881 GTAATCTTACGAGGCTGATCTTTTTTCATTCAGCATAATTCCCTTGAAATCCATCCAAGTTGTTGCATGTATGAATAGTT 961 TCTTCCTTTTTTTCTTTTAAAAATGTTTTATATATTTAGGGGGTATAAGTACAGATTTCTTACATGCATATATTGCATCG 1041 TGGTGAAGTGGGGGCAGTTCCTTTTGATTGCTGAGTAGTATTCCATGGTATGGATGTACCACAGTTTGCTTAACCATTCA 1121 CCCACTAAAGGACATAAGAGTTGTTTTCAGTTTTTTGCCCTAATAAAGCTGCTGTGAACATTCATGTACAGGTTTTTATG 1201 TGAACATACATTTTCATTTTCTGGGATAAATGCTCAAAAGGGCAACTGTTGGGTTGTATGGTAAACACATATATTTTTGT 1281 AAGAAACTACCCTACTCTTTTTCCAGAGTGGCTCTACTTTTTACATACAGCCACTCATACAATTCAGACAGCAATGTATG 1361 ATTGATCCAGTTTCTTCACATCCTCACCAGCATTTGGTATTACTACTATTTTTTATCTTAACCATTCACATAGATGTGTG 1441 TAATGATACCACATGTGGTTTTAATTTGCATTTCCAATGGCTAATGATGTTGAGTATCTTTTTGTGTGCTAATTTGCCAT 1521 CTATGTATCCTCTTCGGTGAAATGTCTTCATGTCTTTTGTCTATTTTCTATTTAGGTCATTTGTTCTTTTTACTATTGAG 1601 TTTTGAGAGGTTTTTTATATATCCTAGATAAAATTCCTCTGTTAGATATGTGGTTGCTTGAATTTTTAACATAACTTCTA 1681 CCAAGGAAAAATAAGTAAAATTTCCAACCCTTGCATGGCCAGTCACTTACTTAATTCCTGTCCTTCAGTGTTCCATCTAG 1761 AGAATTAAGAGATATGATGTATAAAATAGACATCGAGGGCCATTAAGAGAGTAAATACTTAAAAATACATGTTATGAAAG 1841 CAAAGCCAATAATCACTGTAGGAGTATGAGTTGCCTAAGGGCCAAAACTAATGTAAATAAGAGAAAGTGTGGATATAAAT 1921 GACCATTGTTTATAAACAGTTATGAAAAATGCTGTGACTTGAAATCTTTCCCACATCTCCCAAGAAAGTAGGTAGGAGTT 2001 TATCCTTTCCGTAATCTCTTTTTAACCCTGCTGACTATTACAGGGCTTGTTTAATCACAGTGGCAAGAATTACATGTATC 2081 TTACAGTAAAGAAACAGAATACTGGAATCGTTAGAGAACCCTGATGTGTTGACCTGGATAAAGTACAAAGGTGGAAGAGG 2161 GAATGAGTTATGCTGTTAAAATCTCAGGCTATTCTGTTAATGTTCCTGCTACTATGAACCCAAACTTTTTTTTTCCCCCT 2241 TTTGACTCCTTGTGTCTTCCTCTCCTGTGGCATAAAAGTAGTTCTGTCGTTAACTTGTACAACATTGCCATCTGCTGTTG 2321 AGAATTGGTAGGTACTGCTTCTGAGAACCTGGCTGCAGATCCTTAGCATAGGCAGCAAATGTTGAGAAAGTCTATCTGTA 2401 GTATTACATATACTAAGTTACAGAGGATGCATCCAAGTAGAGAAAATAATATGTGGGTTAAGATACATCCTTAAACTTTT 2481 TTTTTTTTGGGGGGGGGGGGACGGAGTCTTGCTGCAACGCCCAGGCTGGAGTGCAATGGCACTATCTCAGCTCGCTGCAA 2561 CCTTCACCTCCTGGGTTCAAGCAATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGAATATAGGTGCACACCACCATGCCT 2641 GGCTAATTTTTGTATTTTCAGTAGAAGCAGAGTTTCACCATATTGGCCAGGTTGGTCTCGAACTCCTGACCTCAAGTGAT 2721 CTGCCTGCCTCAGCCTCCCAAAGTGCTGGGATTACACGCGTGAGCCACCACACCCAGCCTCCATCTTTAAACTTTTAAAT 2801 GTGAAATTTCTATCATGTACCGTTAGCCTAACAAGATTTTCTTTCCTATTTCTGACTGGTGCCTTTCCCCTTTTTAGGAG 2881 CAACGAAAGCTACTCTCTTAGTTATGTTCTTGTGATGTGACAAAATGTCAAGAAGATAGGAGAAGAGAATATTTTATTTC 2961 GTTGATGCTTTTGTTCCCAAGTGTGACCCTAAACTTAAGCTTTGTAGGAGTTGACATTCTTTCATGTCCCTTCCCTTTAC 3041 TCATGCCGAAACTATCAACTGGGACATTTTGTGCTTTTGGTTTAAAAGTTAATTGATATTATACTTTGGTTTTATCTAAA 3121 AAGTAAATGTATTTGCCTTTGACAAAAGACTGACACAAGAGCAAATAAGCTTTAAAATCGGGTGTTATGTGCTTTCCTCC 3201 ATTTTTGAGCATATTATCCAAAATGGTCTGTATAATATAAATGAGAATGATGCAGTTTAAGTAAGCCTTGTTATACCATT 3281 GTCATGGACCCCTGTCATAAAGCCATTTCTTGGTTTGTTTGGGAAAGAGGCATATGGGATTTATACAGATTCACTTGTAA 3361 ATGTTGGATTGGGGATTTTTGTGTAAATTTTCTCAAATAAAGGCTAGCAGAAACCATAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | islets |
Tools used in this research | TargetScan |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Supplenentary. RNA binding protein: AGO.
... - Kameswaran V; Bramswig NC; McKenna LB; Penn et al., 2014, Cell metabolism. |
Article |
- Kameswaran V; Bramswig NC; McKenna LB; Penn et al. - Cell metabolism, 2014
Type 2 diabetes mellitus (T2DM) is a complex disease characterized by the inability of the insulin-producing beta cells in the endocrine pancreas to overcome insulin resistance in peripheral tissues. To determine if microRNAs are involved in the pathogenesis of human T2DM, we sequenced the small RNAs of human islets from diabetic and nondiabetic organ donors. We identified a cluster of microRNAs in an imprinted locus on human chromosome 14q32 that is highly and specifically expressed in human beta cells and dramatically downregulated in islets from T2DM organ donors. The downregulation of this locus strongly correlates with hypermethylation of its promoter. Using HITS-CLIP for the essential RISC-component Argonaute, we identified disease-relevant targets of the chromosome 14q32 microRNAs, such as IAPP and TP53INP1, that cause increased beta cell apoptosis upon overexpression in human islets. Our results support a role for microRNAs and their epigenetic control by DNA methylation in the pathogenesis of T2DM.
LinkOut: [PMID: 24374217]
|
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
65 hsa-miR-539-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT102192 | NAPEPLD | N-acyl phosphatidylethanolamine phospholipase D | 2 | 4 | ||||||||
MIRT147308 | KPNA2 | karyopherin subunit alpha 2 | 2 | 8 | ||||||||
MIRT255970 | WDR17 | WD repeat domain 17 | 2 | 2 | ||||||||
MIRT318225 | RREB1 | ras responsive element binding protein 1 | 2 | 4 | ||||||||
MIRT339123 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT341161 | HNRNPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | 2 | 2 | ||||||||
MIRT439452 | TMED10 | transmembrane p24 trafficking protein 10 | 1 | 1 | ||||||||
MIRT439861 | PTPRS | protein tyrosine phosphatase, receptor type S | 1 | 1 | ||||||||
MIRT440178 | MTRNR2L8 | MT-RNR2-like 8 | 1 | 1 | ||||||||
MIRT440188 | MTRNR2L2 | MT-RNR2-like 2 | 1 | 1 | ||||||||
MIRT440445 | INTS3 | integrator complex subunit 3 | 1 | 1 | ||||||||
MIRT440771 | DST | dystonin | 1 | 1 | ||||||||
MIRT440838 | DDX17 | DEAD-box helicase 17 | 1 | 1 | ||||||||
MIRT440928 | CLTC | clathrin heavy chain | 1 | 1 | ||||||||
MIRT441017 | CANX | calnexin | 1 | 1 | ||||||||
MIRT441020 | CAND1 | cullin associated and neddylation dissociated 1 | 1 | 1 | ||||||||
MIRT441272 | ACTR3C | ARP3 actin related protein 3 homolog C | 1 | 1 | ||||||||
MIRT441275 | ACTR3B | ARP3 actin related protein 3 homolog B | 1 | 1 | ||||||||
MIRT446564 | IDS | iduronate 2-sulfatase | 2 | 2 | ||||||||
MIRT458674 | MRI1 | methylthioribose-1-phosphate isomerase 1 | 2 | 2 | ||||||||
MIRT467486 | SMIM13 | small integral membrane protein 13 | 2 | 2 | ||||||||
MIRT471515 | PCGF3 | polycomb group ring finger 3 | 2 | 6 | ||||||||
MIRT488211 | TESK2 | testis-specific kinase 2 | 2 | 6 | ||||||||
MIRT505413 | TCF7L2 | transcription factor 7 like 2 | 2 | 4 | ||||||||
MIRT506405 | NRF1 | nuclear respiratory factor 1 | 2 | 4 | ||||||||
MIRT508095 | ANKRD33B | ankyrin repeat domain 33B | 2 | 4 | ||||||||
MIRT511883 | GAS1 | growth arrest specific 1 | 2 | 6 | ||||||||
MIRT513413 | RTP4 | receptor transporter protein 4 | 2 | 2 | ||||||||
MIRT515814 | FOCAD | focadhesin | 2 | 2 | ||||||||
MIRT522747 | LNPEP | leucyl and cystinyl aminopeptidase | 2 | 2 | ||||||||
MIRT526664 | IL5RA | interleukin 5 receptor subunit alpha | 2 | 6 | ||||||||
MIRT532113 | G6PC | glucose-6-phosphatase catalytic subunit | 2 | 2 | ||||||||
MIRT547536 | MAML3 | mastermind like transcriptional coactivator 3 | 2 | 2 | ||||||||
MIRT554605 | RPS6KA5 | ribosomal protein S6 kinase A5 | 2 | 2 | ||||||||
MIRT554884 | RCAN2 | regulator of calcineurin 2 | 2 | 2 | ||||||||
MIRT555859 | PANK3 | pantothenate kinase 3 | 2 | 2 | ||||||||
MIRT556601 | LDOC1L | retrotransposon Gag like 6 | 2 | 4 | ||||||||
MIRT565169 | LINC00598 | long intergenic non-protein coding RNA 598 | 2 | 2 | ||||||||
MIRT567099 | KANSL1 | KAT8 regulatory NSL complex subunit 1 | 2 | 2 | ||||||||
MIRT575032 | Fasl | Fas ligand (TNF superfamily, member 6) | 1 | 1 | ||||||||
MIRT609327 | TAS2R30 | taste 2 receptor member 30 | 2 | 4 | ||||||||
MIRT609394 | C11orf74 | chromosome 11 open reading frame 74 | 2 | 2 | ||||||||
MIRT613120 | SRCAP | Snf2 related CREBBP activator protein | 2 | 2 | ||||||||
MIRT614273 | WSCD2 | WSC domain containing 2 | 2 | 2 | ||||||||
MIRT614988 | GID4 | GID complex subunit 4 homolog | 2 | 4 | ||||||||
MIRT619483 | QSOX2 | quiescin sulfhydryl oxidase 2 | 2 | 2 | ||||||||
MIRT622061 | SS18 | SS18, nBAF chromatin remodeling complex subunit | 2 | 2 | ||||||||
MIRT627045 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT657273 | HS3ST3B1 | heparan sulfate-glucosamine 3-sulfotransferase 3B1 | 2 | 2 | ||||||||
MIRT658285 | FASLG | Fas ligand | 2 | 3 | ||||||||
MIRT660838 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT665552 | UCHL5 | ubiquitin C-terminal hydrolase L5 | 2 | 2 | ||||||||
MIRT687560 | MGAT5 | mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase | 2 | 2 | ||||||||
MIRT698864 | SRSF2 | serine and arginine rich splicing factor 2 | 2 | 2 | ||||||||
MIRT699509 | SKIL | SKI like proto-oncogene | 2 | 2 | ||||||||
MIRT706255 | MKLN1 | muskelin 1 | 2 | 2 | ||||||||
MIRT711973 | HOMER2 | homer scaffolding protein 2 | 2 | 2 | ||||||||
MIRT718038 | NIPAL2 | NIPA like domain containing 2 | 2 | 2 | ||||||||
MIRT718766 | ABHD15 | abhydrolase domain containing 15 | 2 | 2 | ||||||||
MIRT721319 | GRHL1 | grainyhead like transcription factor 1 | 2 | 2 | ||||||||
MIRT721439 | NGDN | neuroguidin | 2 | 2 | ||||||||
MIRT721977 | RAD50 | RAD50 double strand break repair protein | 2 | 2 | ||||||||
MIRT725374 | MTF2 | metal response element binding transcription factor 2 | 2 | 2 | ||||||||
MIRT737461 | CTBP1 | C-terminal binding protein 1 | 4 | 0 | ||||||||
MIRT755390 | Sox9 | SRY-box 9 | 4 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|